SECURITIES AND EXCHANGE COMMISSION
                   
                        Washington, D.C.  20549
                        
                                FORM 8-K
                             CURRENT REPORT

                 Pursuant to Section 13 or 15(d) of the
                     Securities Exchange Act of 1934

             Date of Earliest Event Reported:  July 15, 1996

                               USANA, INC.
         (Exact name of registrant as specified in its charter)


         Utah                   0-211160 
(State of Incorporation)  (Commission File No.)

      87-0500306
(IRS Employer Identification No.)


                           4550 South Main Street
                         Salt Lake City, Utah 84107
                 (Address of Principal Executive Offices)

                               (801) 288-2290
               (Issuer's Telephone Number, Including Area Code)


Item 5.  Other Events.

     Effective July 15, 1996, the Board of Directors of USANA, Inc., a
Utah corporation (the "Company"), acted by unanimous written consent to
increase the number of directors on the Company's Board of Directors from
3 directors to 5 directors, and to appoint Suzanne Winters, Ph.D., and
Robert Anciaux to fill the positions thus created.  Dr. Winters and Mr.
Anciaux have accepted their respective appointments.  All directors of the
Company, including the new appointees, serve as directors until the next
annual meeting of shareholders and until their successors are elected and
have been qualified.

     Also effective July 15, 1996, the Board of Directors appointed two
independent directors of the Company, Ronald S. Poelman and Robert
Anciaux, to constitute an Audit Committee of the Company's Board of
Directors.

     The full Board of Directors of the Company now consists of the
following 5 individuals:

          Dr. Myron Wentz
          Ronald S. Poelman
          David Wentz
          Dr. Suzanne Winters
          Robert Anciaux

     Biographical information regarding the two new directors follows:

     Suzanne Winters, age 42, has been, since June 1993, State Science
Advisor for the State of Utah.  As such, she has advised the Governor and
the Legislature of the State of Utah on matters relating to science and
technology and their applications to government, industry and public
issues.  From November 1990 to June 1993, Dr. Winters was employed as the
President of MC2 -- Membranes and Coatings Consultants, Inc., a Salt Lake
City, Utah-based business that provides management services with respect
to research and development for implantable, continuous, self-calibrating
blood gas, pH, and electrolyte sensors and intravenous bubble oxygenators,
and other technology-related management services.  Dr. Winters was awarded
her doctorate in Pharmaceutics by the University of Utah in 1986.  She is
affiliated with the American Chemical Society, the Biomaterials Society,
the American Association for the Advancement of Science, the American
Society for Artificial Organs, and the Science and Technology Council of
the States.

     Robert Anciaux, age 51, is a resident of Brussels, Belgium.  Since
1982, Mr. Anciaux has been self-employed as a venture capitalist.  During
the past 10 years he has been active as a venture capitalist in Europe,
investing in various commercial, industrial and real estate venture
companies in Belgium and abroad.  He also has been involved for a number
of years as a shareholder of various companies that manage institutional
or private investment funds.  In some of these privately-held companies
Mr. Anciaux has also served as a director.  

                              SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.


                                  USANA, INC.

                                  By: /s/  GILBERT FULLER
                                  Gilbert Fuller, Chief Financial Officer


Dated: July 18, 1996